CAMP
Camp4 Therapeutics CorpCompany with tickers: CAMP
CIK
1736730
CUSIP
13463J101
Shares Outstanding
51,925,800
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $1,294,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $14,365,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $10,160,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-13,071,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-18,331,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.32 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.32 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |